XBiotech Inc

Company Profile

XBiotech Inc had its IPO on 2015-04-15 under the ticker symbol XBIT.

The company operates in the Healthcare sector and Biotechnology industry. XBiotech Inc has a staff strength of 85 employees.

Stock update

Shares of XBiotech Inc opened at $3.25 at the start of the last trading session i.e. 2023-03-22.

The stocks traded within a range of $3.25 - $3.49, and closed at $3.35.

This is a +2.76% increase from the previous day's closing price.

A total volume of 12,365 shares were traded at the close of the day’s session.

In the last one week, shares of XBiotech Inc have increased by +2.76%.

XBiotech Inc's Key Ratios

XBiotech Inc has a market cap of $103.19 million, indicating a price to book ratio of 0.4053 and a price to sales ratio of 11.901.

In the last 12-months XBiotech Inc’s revenue was $4.01 million with a gross profit of $3.36 million and an EBITDA of $-31876000. The EBITDA ratio measures XBiotech Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, XBiotech Inc’s operating margin was -860.1% while its return on assets stood at -8.27% with a return of equity of -12.91%.

In Q4, XBiotech Inc’s quarterly earnings growth was a positive 0% while revenue growth was a negative 93.3%.

XBiotech Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

0

Its diluted EPS in the last 12-months stands at $-1.05 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into XBiotech Inc’s profitability.

XBiotech Inc stock is trading at a EV to sales ratio of 0.686 and a EV to EBITDA ratio of 3.9436. Its price to sales ratio in the trailing 12-months stood at 11.901.

XBiotech Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$246.10 million

Total Liabilities

$4.07 million

Operating Cash Flow

$-3907000.00

Capital Expenditure

$375000

Dividend Payout Ratio

0%

XBiotech Inc ended 2023 with $246.10 million in total assets and $0 in total liabilities. Its intangible assets were valued at $246.10 million while shareholder equity stood at $240.40 million.

XBiotech Inc ended 2023 with $0 in deferred long-term liabilities, $4.07 million in other current liabilities, 267325000.00 in common stock, $-27749000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $157.31 million and cash and short-term investments were $157.31 million. The company’s total short-term debt was $0 while long-term debt stood at $0.

XBiotech Inc’s total current assets stands at $219.84 million while long-term investments were $0 and short-term investments were $60.17 million. Its net receivables were $1.22 million compared to accounts payable of $2.41 million and inventory worth $0.

In 2023, XBiotech Inc's operating cash flow was $-3907000.00 while its capital expenditure stood at $375000.

Comparatively, XBiotech Inc paid $0 in dividends in 2023.

Other key metrics

Current Trading Price

$3.35

52-Week High

$9.37

52-Week Low

$3

Analyst Target Price

$

XBiotech Inc stock is currently trading at $3.35 per share. It touched a 52-week high of $9.37 and a 52-week low of $9.37. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $3.79 and 200-day moving average was $4.13 The short ratio stood at 2.14 indicating a short percent outstanding of 0%.

Around 3686.7% of the company’s stock are held by insiders while 1303.9% are held by institutions.